GEODE CAPITAL MANAGEMENT, LLC
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1214717
BOSTON, MA
Position in HRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,836,521
-$1,371,547 QoQ
Shares Held
4,270,980
+6.5% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. HRTX ranks #292 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,836,521 | 4,270,980 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,208,068 | 4,010,087 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,305,588 | 4,081,222 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,590,156 | 3,642,982 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,383,302 | 3,566,813 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $6,850,201 | 3,113,728 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,613,450 | 3,015,327 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,060,267 | 3,045,361 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,893,172 | 3,112,335 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,745,249 | 2,796,119 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,461,945 | 2,624,674 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,467,015 | 2,395,161 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,383,134 | 2,054,426 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,982,180 | 1,974,954 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,896,105 | 1,958,442 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,706,981 | 1,826,299 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,057,248 | 1,812,634 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,405,739 | 1,644,360 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,626,981 | 1,711,608 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $17,236,288 | 1,612,375 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $24,667,363 | 1,589,392 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $23,360,960 | 1,441,145 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,619,885 | 1,304,671 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,633,037 | 1,257,290 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,655,016 | 1,268,186 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $14,176,179 | 1,207,511 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||